This $615,999 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope, a nonprofit organization. The grant funds research to develop a "Targeted Telomere-Disrupting Oligonucleotide for Acute Myeloid Leukemia Therapy" over a 3-year period from Sep 1, 2023 to Aug 31, 2026. As a nonprofit research organization, Beckman Research Institute leverages its medical research expertise and capabilities to support federal projects aimed at improving healthcare and developing innovative solutions. The institute has extensive experience partnering with various government agencies and organizations as a prime contractor, subcontractor, prime grantee, and subgrantee across diverse health-related research areas.
Generated 5/7/24, 1:23 AM